Investor Relations
Changing the Future

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests and that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Learn More

Latest News
Loading...
Stock Information
NASDAQCODX
Events
Thursday, December 1, 2022
11:30am - 11:50am EST

Co-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference

Thursday, November 10, 2022
4:30pm - 5:30pm EST

Co-Diagnostics, Inc. Q3 2022 Earnings Webcast

All Events